Neuro-Bio
1 known investors
Find your way into Neuro-Bio
Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease. Its work centers on a novel molecule, T14, identified as a driver of neurodegeneration, to build a pre-symptomatic biomarker and drug.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CMar 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neuro-Bio do?
- Neuro-Bio is a privately owned biotech focused on neurodegenerative diseases, developing diagnostic and therapeutic strategies for Alzheimer's disease. Its work centers on a novel molecule, T14, identified as a driver of neurodegeneration, to build a pre-symptomatic biomarker and drug.
- Who are Neuro-Bio's investors?
- Neuro-Bio's investors include Kairos Venture Investments, Llc.